TEHRAN, May 27 (MNA) – Mortality rate after the use of the Pfizer coronavirus vaccine in six European countries is significantly higher than after the AstraZeneca vaccine, the company's report, showed. The Moscow office of the vaccine manufacturer confirmed to Sputnik the authenticity of the do...
DAMIAN J. TROISE
All 19 people who experienced so-called anaphylactic reactions after the Moderna vaccine were women. Women comprised 44 of the 47 individuals who experienced an anaphylactic reaction after the Pfizer vaccine. Most of the people who developed a rare blood clot problem after the AstraZenecavaccinewere ...
Pet Cancer, Pet Health, Pet Vaccines, rabies, Vaccine Side Effects, Veterinary Medicine 06/18/2024 Stop Vaccinating Your Seniors, Already! Reprinted with permission from Dr. Will Falconer, DVM This just came to my support email: My vet wants to give the rabies vaccine to my 14 year old ...
Vaccine side effects in people who have had coronavirus Liu said that data from the original clinical trails showed that "those who had COVID already had somewhat more side effects" compared to people who did not, but said those results were "not that surprising." ...
He had received the BNT162b2 mRNA vaccine (BioNTech/Pfizer) four times in the past, and the only side effect after vaccination was fever, which improved within a few days. This was the first time he had received the mRNA-1273 COVID-19 vaccine. On presentation, his vital signs were a ...
A Georgia pediatrician reported experiencing sinus tachycardia and small-fiber neuropathy three days after taking a second dose of the Pfizer vaccine. “When my neurological symptoms began, I was terrified that I would lose my ability to practice medicine because the weakness was so significant,” ...
The global influenza vaccine market size was valued at $5024.60 million in 2020, and is projected to registering at a CAGR of 7.20% from 2021 to 2030.
A 30-year-old woman with no significant past medical history presented with left axillary lymphadenopathy 12 days after the first dose of messenger RNA (mRNA)-based COVID-19 vaccine (Pfizer-BioNTech) in her left arm. She had no fever or other inflammatory symptoms. An ultrasound revealed lymph...
August 2024: Pfizer and BioNTech announced top-line results from their Phase 3 clinical trial evaluating a combined mRNA vaccine candidate against influenza and COVID-19 in healthy individuals aged 18-64. The combination vaccine met one of its two primary immunogenicity objectives. July 2024: Thermo...